245 related articles for article (PubMed ID: 25064455)
21. Novel progressive acrodysostosis-like skeletal dysplasia, cerebellar atrophy, and ichthyosis.
Velasco HM; Ullah E; Martin AM; Hufnagel RB; Prada CE
Am J Med Genet A; 2020 Oct; 182(10):2214-2221. PubMed ID: 32783359
[TBL] [Abstract][Full Text] [Related]
22. [Genetic analysis of a child with acrodysostosis type 2].
Wang L; Li Q; Li X; Wang Y; Li J; Wang J; Wang X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct; 37(10):1128-1131. PubMed ID: 32924117
[TBL] [Abstract][Full Text] [Related]
23. [Heterozygous variation identified in PDE4D gene caused acrodysostosis].
Wang JL; Yuan JN; Huang K; Zhang L; Dong GP
Zhonghua Er Ke Za Zhi; 2019 Nov; 57(11):889-890. PubMed ID: 31665847
[TBL] [Abstract][Full Text] [Related]
24. Screening of PRKAR1A and PDE4D in a Large Italian Series of Patients Clinically Diagnosed With Albright Hereditary Osteodystrophy and/or Pseudohypoparathyroidism.
Elli FM; Bordogna P; de Sanctis L; Giachero F; Verrua E; Segni M; Mazzanti L; Boldrin V; Toromanovic A; Spada A; Mantovani G
J Bone Miner Res; 2016 Jun; 31(6):1215-24. PubMed ID: 26763073
[TBL] [Abstract][Full Text] [Related]
25. Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance.
Linglart A; Menguy C; Couvineau A; Auzan C; Gunes Y; Cancel M; Motte E; Pinto G; Chanson P; Bougnères P; Clauser E; Silve C
N Engl J Med; 2011 Jun; 364(23):2218-26. PubMed ID: 21651393
[TBL] [Abstract][Full Text] [Related]
26. Engineered stabilization and structural analysis of the autoinhibited conformation of PDE4.
Cedervall P; Aulabaugh A; Geoghegan KF; McLellan TJ; Pandit J
Proc Natl Acad Sci U S A; 2015 Mar; 112(12):E1414-22. PubMed ID: 25775568
[TBL] [Abstract][Full Text] [Related]
27. UCR1C is a novel activator of phosphodiesterase 4 (PDE4) long isoforms and attenuates cardiomyocyte hypertrophy.
Wang L; Burmeister BT; Johnson KR; Baillie GS; Karginov AV; Skidgel RA; O'Bryan JP; Carnegie GK
Cell Signal; 2015 May; 27(5):908-22. PubMed ID: 25683917
[TBL] [Abstract][Full Text] [Related]
28. Identification of a multifunctional docking site on the catalytic unit of phosphodiesterase-4 (PDE4) that is utilised by multiple interaction partners.
Houslay KF; Christian F; MacLeod R; Adams DR; Houslay MD; Baillie GS
Biochem J; 2017 Feb; 474(4):597-609. PubMed ID: 27993970
[TBL] [Abstract][Full Text] [Related]
29. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF.
Pullamsetti SS; Banat GA; Schmall A; Szibor M; Pomagruk D; Hänze J; Kolosionek E; Wilhelm J; Braun T; Grimminger F; Seeger W; Schermuly RT; Savai R
Oncogene; 2013 Feb; 32(9):1121-34. PubMed ID: 22525277
[TBL] [Abstract][Full Text] [Related]
30. Acrodysostosis: A new form of pseudohypoparathyroidism?
Silve C
Ann Endocrinol (Paris); 2015 May; 76(2):110-2. PubMed ID: 25890446
[No Abstract] [Full Text] [Related]
31. Fourteen-year follow-up of a child with acroscyphodysplasia with emphasis on the need for multidisciplinary management: a case report.
Kartalias K; Gillies AP; Peña MT; Estrada A; Bulas DI; Ferreira CR; Tosi LL
BMC Med Genet; 2020 Sep; 21(1):189. PubMed ID: 32993552
[TBL] [Abstract][Full Text] [Related]
32. Selective SUMO modification of cAMP-specific phosphodiesterase-4D5 (PDE4D5) regulates the functional consequences of phosphorylation by PKA and ERK.
Li X; Vadrevu S; Dunlop A; Day J; Advant N; Troeger J; Klussmann E; Jaffrey E; Hay RT; Adams DR; Houslay MD; Baillie GS
Biochem J; 2010 Apr; 428(1):55-65. PubMed ID: 20196770
[TBL] [Abstract][Full Text] [Related]
33. Pseudohypoparathyroidism and Gsα-cAMP-linked disorders: current view and open issues.
Mantovani G; Spada A; Elli FM
Nat Rev Endocrinol; 2016 Jun; 12(6):347-56. PubMed ID: 27109785
[TBL] [Abstract][Full Text] [Related]
34. Structure of a PKA RIα Recurrent Acrodysostosis Mutant Explains Defective cAMP-Dependent Activation.
Bruystens JG; Wu J; Fortezzo A; Del Rio J; Nielsen C; Blumenthal DK; Rock R; Stefan E; Taylor SS
J Mol Biol; 2016 Dec; 428(24 Pt B):4890-4904. PubMed ID: 27825928
[TBL] [Abstract][Full Text] [Related]
35. Phosphodiesterase 4B knockout prevents skeletal muscle atrophy in rats with burn injury.
Balasubramaniam A; Sheriff S; Friend LA; James JH
Am J Physiol Regul Integr Comp Physiol; 2018 Aug; 315(2):R429-R433. PubMed ID: 29693432
[TBL] [Abstract][Full Text] [Related]
36. Expression of the cAMP-phosphodiesterase PDE4D isoforms and age-related changes in follicle-stimulating hormone-stimulated PDE4 activities in immature rat sertoli cells.
Levallet G; Levallet J; Bouraïma-Lelong H; Bonnamy PJ
Biol Reprod; 2007 May; 76(5):794-803. PubMed ID: 17215491
[TBL] [Abstract][Full Text] [Related]
37. Noncanonical protein kinase A activation by oligomerization of regulatory subunits as revealed by inherited Carney complex mutations.
Jafari N; Del Rio J; Akimoto M; Byun JA; Boulton S; Moleschi K; Alsayyed Y; Swanson P; Huang J; Martinez Pomier K; Lee C; Wu J; Taylor SS; Melacini G
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34006641
[TBL] [Abstract][Full Text] [Related]
38. Critical role of PDE4D in beta2-adrenoceptor-dependent cAMP signaling in mouse embryonic fibroblasts.
Bruss MD; Richter W; Horner K; Jin SL; Conti M
J Biol Chem; 2008 Aug; 283(33):22430-42. PubMed ID: 18508768
[TBL] [Abstract][Full Text] [Related]
39. Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling.
Li YF; Cheng YF; Huang Y; Conti M; Wilson SP; O'Donnell JM; Zhang HT
J Neurosci; 2011 Jan; 31(1):172-83. PubMed ID: 21209202
[TBL] [Abstract][Full Text] [Related]
40. Identification of novel pathogenic variants and features in patients with pseudohypoparathyroidism and acrodysostosis, subtypes of the newly classified inactivating PTH/PTHrP signaling disorders.
Truelove A; Mulay A; Prapa M; Casey RT; Adler AI; Offiah AC; Poole KES; Trotman J; Al Hasso N; Park SM
Am J Med Genet A; 2019 Jul; 179(7):1330-1337. PubMed ID: 31041856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
